Join us to understand how critically important the genetic and epigenetic changes in cancer are for disease biology and novel treatments.
There are 30 free bursary places available on a first come, first served basis. To claim your free place, please email us at [email protected].
Learning objectives include:
- The role of genetic and epigenetic changes in cancer biology with examples of how this has already impacted patient treatment and survival
- Novel emerging technologies such as gene-editing and radiomics to understand how these may lead to new therapies and predictors of response, respectively
- Gain an insight into the trials and tribulations of genetic testing from a consumer point of view
This meeting will be relevant to clinical and medical oncologists, geneticists, basic scientists interested in cancer biology and genetics (cancer researchers), radiologist, pathologists, pharmacists, cancer researchers and cancer nurses, medical students and trainees interested in cancer and genetics.
A CPD certificate with CPD credit will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.
This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 60 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
Join in the conversation online
Follow us on Twitter: @RoySocMed
Key Speakers:
Professor Alan Ashworth
E. Dixon Heise Distinguished Professor in Oncology, University of California San Francisco, President, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, Senior Vice President for Cancer Services, University of California San Francisco Health, Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, United States of America
Professor Clare Scott
Professor of Gynaecological Cancer, University of Melbourne, Joint Head, Clinical Translation Centre, Laboratory Head, Walter and Eliza Hall Institute of Medical Research, Medical Oncologist, Peter MacCallum Cancer Centre, Royal Melbourne and Royal Women’s Hospitals, Australia
Professor Ian Tomlinson
Director, Cancer Research UK Edinburgh Centre, Charles and Ethel Barr Chair of Cancer Research
The origins of the Royal Society of Medicine date back to the 18th century when, throughout Europe, medical societies began to be founded with the object of bringing together physicians and surgeons.
- The Golden Age of Melancholy, Royal Society of Medicine Library - 16th January 2023
- Health experts fear impact of deteriorating hostile environment - 26th February 2022
- Update on cancer genetics, epigenetics and resulting therapeutics - 11th January 2022
